GSTP1 and prostate carcinoma: Additionally, tetra-hydroxynonenal (4-HNE), a common byproduct of lipid peroxidation, was found to be reduced in GSTP1-positive prostate cancer patients compared to GSTP1-negative patients, indicating that GSTP1 protects lipids from oxidative damage [68].